A decline of 830 cases has been recorded in the active Covid-19 caseload in a span of 24 hours and over 136 crore vaccine doses have been administered so far under the Nationwide Vaccination Drive. But this achievement seems to have been overshadowed by the rising number of Omicron cases in the country.
Coronavirus Vaccine Registration, Coronavirus Omicron Variant Cases in India Live Updates: India recorded a total of 7,145 new Covid-19 cases and 289 deaths in last 24 hours, as per the data shared by the Union Health Ministry on Saturday morning. The data also highlighted that a total of 8706 recoveries were made in last 24 hours which has taken the total recovery toll to 3,41,71,471. The recovery rate currently stands at 98.38% which is the highest since March 2020.
India’s active caseload stands at 84,565 which is the lowest in 569 days. A decline of 830 cases has been recorded in the active Covid-19 caseload in a span of 24 hours. Over 136 crore vaccine doses have also been administered so far under the Nationwide Vaccination Drive. But this achievement seems to have been overshadowed by the rising number of Omicron cases in the country.
In a weekly press briefing on Friday, Lav Agrawal, Joint Secretary, Health Ministry highlighted the increasing global threat of Omicron cases and urged the people to avoid unneccessary travelling. Agrawal said that India has so far reported 101 cases of the Omicron variant across 11 states. The ministry also flagged the fast spread of Omicron which is a major cause of concern for the government. “Omicron is spreading faster than the Delta variant in South Africa, where Delta circulation was low. It also appears to spread more quickly than Delta in places where the incidence of Delta is high, such as in the United Kingdom,” Agrawal said.
The Ministry has been warning people to avoid mass gatherings, especially around New year due to the rising number of Omicron cases, and the caution was again raised on Friday by Dr. Balram Bhargava, DG ICMR. “This is the time to avoid non-essential travel, mass gatherings and it is very important to observe low-intensity festivities (Christmas, New Year),” Bhargava said.
In another global development, the World Health Organization has issued an emergency use listing for Covovax, the anti-Covid vaccine being produced by the Pune-based Serum Institute of India (SII) under license from Novavax. SII CEO Adar Poonawalla said, “This is yet another milestone in our fight against Covid-19, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy.”
Financial Express Online brings you the latest updates on the Coronavirus pandemic. Stay tuned.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
